Fred Karlinsky appointed to GBLI Board of Directors effective December 5, 2023

Global Indemnity Group, LLC

Fred Karlinsky joined GBLI Board effective Dec 5, 2023, appointed under Class B Majority Shareholder's rights.
Karlinsky is Co-Chair of Greenberg Traurig’s Global Insurance Regulatory Practice Group with 30+ years experience.
Serves on Conflicts, Nomination, Compensation & Governance, Enterprise Risk Mgmt, and Technology Committees.
Agreement gives Class B Majority Shareholder right to remove Karlinsky at any time; he must resign upon request.
No other material arrangements or transactions with GBLI; standard director compensation applies.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Fred Karlinsky

Director

GBLI · Global Indemnity Group, LLC

Effective: 2023-12-05
Filed: December 7, 2023, 6:59 PM ET

Effective December 5, 2023, Fred Karlinsky joined the Board of Directors of Global Indemnity Group, LLC (“GBLI”) pursuant to the Class B Majority Shareholder’s rights under GBLI’s Second Amended and Restated Limited Liability Company Agreement.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Fred Karlinsky was appointed as Director at Global Indemnity Group, LLC.

Action: joined
Role: Director

Exact text from the filing

Effective December 5, 2023, Fred Karlinsky joined the Board of Directors of Global Indemnity Group, LLC (“GBLI”) pursuant to the Class B Majority Shareholder’s rights under GBLI’s Second Amended and Restated Limited Liability Company Agreement.

View on SEC.gov

Global Indemnity Group, LLC filing history →

Source: SEC EDGAR

accession 0001193125-23-290687

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.